Shaw Christi 4
4 · LILLY ELI & CO · Filed May 7, 2019
Insider Transaction Report
Form 4
Shaw Christi
SVP and Pres., Lilly Bio-Meds
Transactions
- Sale
Common Stock
2019-05-03$117.99/sh−500$58,995→ 0 total - Sale
Common Stock
2019-05-03$117.08/sh−7,077$828,575→ 500 total
Footnotes (3)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $117.82 to $118.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.